Review Article
of the bacteria probably may be due to few factors, and one among them is age where a predominance of Bacteroides, Alistipes, Sporobacter, Dorea, Faecalibacterium, Roseburia and Ruminococcus are observed more in elderly aged than the younger age group. [6] The gut microbiota is mainly divided into three enterotypes each dominated by a different genus Bacteroides, Prevotella or Ruminococcus and are not affected by gender, age or nationality and not being limited to humans race alone. [7] In enterotype 1, the main contributor is Bacteroides; however, co-occurring genera with positive correlation are Alkaliphilus, Lactobacillus, Parabacteroides, Clostridiales and Slackia, and those with negative correlation are Catenibacterium, Methanobrevibacter and Geobacter. Prevotella is the main contributor in enterotype 2 with co-occurring contributors in positive correlation are Veillonella, Helicobacter, Leuconostoc, Staphylococcus, Holdermania, Rhodospirillum, Desulfovibrio, Eggerthella and Ruminococcaceae and in negative correlation is Escherichia, Shigella and Akkermansia. Enterotype 3 shows a predominance of Ruminococcus and positively co-occurring genera are Gordonibacter, Akkermansia, Staphylococcus, Dialister, Symbiobacterium, Marvinbryantia, Ruminococcaceae and negative correlation of Sphingobacterium. [7] phySiOlOgical and epideMiOlOgical variatiOnS in gut MicrOBiOta
Age related
The mode of birth (vaginally delivered or caesarean section) influences the gut microbiota of the newborn. Transitions in gut microbiota were observed at various stages of life such as infants, toddlers, adults and elderly. In the breastfed babies, gut microbiota shows a significant transition when they are weaned to solid and more diverse food. Actinobacteria is more abundant during weaning, decreases in the post-weaning period and continues to decrease with increase in age. Firmicutes is more abundant in children >4 years when compared to children <4 years. Proteobacteria is more abundant in elderly (>70 years). Children slowly establish the adult-like gut microbiota by 3-4 years of age. Elderly individuals tend to have more gut microbial dysbiosis which results in low-grade inflammation. There is increased abundance of Enterobacteriaceae in the elderly which contributes to the low-grade inflammation due to LPS resulting in metabolic endotoxaemia. Bifidobacterium which downregulates the pro-inflammatory markers reduces as individuals get older. Preliminary study conducted on sibling mice from different litters and their offspring showed that all shared a similar microbial composition. [8] Obese and lean monozygotic and dizygotic twins shared the same microbial flora among them as well as with their mothers indicating that it is inherited. [9] 
Gender related
Contrasting reports have been published on differences in microbial composition based on gender. No significant differences in gut microbiota were observed between males and females. [7, 10, 11] However, when gut microbiota is transferred from a man to gnotobiotic mice the gut of male and female mice tend to lodge the microbiota differently. Prevotella, Megamonas and Fusobacteria were abundant in male Japanese patients in contrast Bifidobacterium, Ruminococcus and Akkermansia were abundant in female Japanese patients. The differences in gut microbiota were established in gonadectomised and hormone-treated mice, suggesting the role of sexual hormones influencing gut microbiota. [12] Exercise Differences in the composition of gut microbiota have been documented based on active versus sedentary lifestyle. Higher abundance of health-promoting bacterial species such as Faecalibacterium prausnitzii, Roseburia hominis and Akkermansia muciniphila were found among active women; Paraprevotella and Desulfovibrionacea were documented in sedentary women. Obese adolescents who were put on a calorie restriction with increased physical activity regimen showed increase in Bacteroidetes, Prevotella and decrease in Clostridia.
Diet and feeding habits
The gut of herbivorous animal differs from carnivorous animals. The gut microbiota of herbivorous is highly diverse with 14 different phyla in contrast to carnivorous with only six different phyla. The gut of vaginally delivered infant is colonised by Enterobacteria and Streptococci. [13] The gut of breastfed infant is predominated by Bifidobacteria, while those of bottle-fed infant have a more diverse flora [13, 14] consisting of Enterobacteriaceae and Enterococci. [13] Influence of formula feeds versus breastfeeding on gut microbiota has been elegantly demonstrated. Studies have shown an abundance of Bifidobacterium in the gut of exclusive breastfed infants than on babies who were on formula feeds. [13] African children who consumed high amounts of plant polysaccharides had high number of Bacteroidetes (Prevotella and Xylanibacter); known to degrade cellulose and xylans, than Italian children who had more number of Enterobacteriaceae (Shigella and Escherichia) indicating that the African children had adapted to extract maximum energy from a fibre-rich diet. [1] A unique feature has been noted that Japanese can digest sea weeds, although the human body does not have any enzymes to digest these sea weeds. This is because their gut flora has acquired a specific set of enzyme similar to the one present in marine bacteria (Zobellia galactanivorans). In another study conducted between children, adults and twins from the same as well as different families among Amerindians, Malawian communities and subjects of the Unites State of America (USA), it was observed that interpersonal variation in children was more than adults. The faecal microbiota was also different between the patients of the USA who consumed protein diet and subjects of Amerindian and Malawian communities who consumed plant polysaccharides. [10] The physiological and epidemiological variation in gut microbiota is driven by diet, exercise and genetic pre-disposition that results in an identity being created. Obesity lined up with insulin resistance could be a probable cause for type 2 diabetes. Strikingly both diabetes and obesity show in a picture of a chronic low-grade inflammation along with many inflammatory mediators such as tumour necrosis factor and interleukins (ILs). [15] The evidence of alteration of gut microbiota contributing to the development of pathological conditions is increasing.
pathOlOgical cOnditiOnS where gut MicrOBiOta iS altered

Obesity
The caecal microbiota of genetically obese mice contained a lesser amount of Bacteroidetes than Firmicutes when compared with their lean mates. [8] Among obese and normal weight Egyptian children and adults, it was found that bacteria belonging to phyla Firmicutes and Bacteroidetes were increased in obese individuals. [16] Firmicutes was abundant in patients with increased intake of fat, whereas those who had increased intake of carbohydrates Bacteroidetes and Firmicutes were observed to be abundant. [16] A study at a tertiary care centre in Chennai analysed gut microbiota of type 2 diabetes mellitus (T2DM) individuals and non-diabetics, and at a phyla level, it was observed that Firmicutes in both T2DM and non-diabetic individuals showed 49%, Proteobacteria was 32% in T2DM, but in non-diabetic, it was 26%, Bacteroidetes was 17% among T2DM, whereas in non-diabetic is slightly higher which is 18%, Actinobacteria is higher in non-diabetic individuals which is 7%, and in diabetic individuals, it is 2%. It was also observed that the rise in body mass index among T2DM individuals showed a predominance of Gram-negative bacteria than in the non-diabetic participants of the study. [17] Inflammatory Ulcerative colitis (UC) and Crohn's disease (CD) are the most common inflammatory bowel diseases, [18] where the gut microbiota plays a key role in the development of inflammatory disease. The exact role of gut flora has not been defined, although it has been found that there is a high degree of interindividual variability [19] and disturbance or losses in the normal microbial content of the gut play a role in the development of inflammatory bowel diseases. [20] Inflammatory bowel disorder (IBD) is generally due to an intense immune response in individuals who have a genetic predisposition. Transforming growth factor production from epithelial cells and IL-10 from mononuclear cells mediate anti-inflammatory responses. [21] IBD is multifactorial and a chronic condition of the gastrointestinal tract; it includes CD and UC. The dramatic changes in the gut microbiota may be associated with IBD. Microbial enzymes that are enriched in IBD are magnesium-importing ATPase, ethanolamine ammonia-lyase and glutathione reductase, whereas in healthy controls, the microbial enzymes are pyruvate synthase and precorrin-2-dehydrogenase. In non-IBD controls, the elevated species were Roseburia hominis, Dorea formicigenerans and Ruminococcus obeum. In IBD participants, it was observed that many of these species were drastically depleted. There is a significant raise in unclassified Roseburia species in UC and CD patients. In CD, the enriched species includes Ruminococcus gnavus, Escherichia coli and Clostridium clostridioforme, whereas in UC, there is a unique abundance of Bifidobacterium breve and Clostridium symbiosum. Enterochromaffin cells (EC) in the gut is a site of secretion of serotonin (5-hydroxytryptamine [5-HT]). Tryptophan hydroxylase 1 (TPH1) is a rate-limiting enzyme for synthesis of . The changes in intestinal serotonin was observed in colitis and inflammatory bowel disease (IBD). Elevated levels of serotonin in the gut mucosa make the gut microbiota more colitogenic. Serotonin acts both directly and indirectly, directly regulates the gut flora species and indirectly acts via β-defesins. Studies on Tph +/and Tph -/mice exhibited an abundance of Proteobacteria in both groups. A reduction in Bacteroidetes and raise in Firmicutes was observed in Tph +/mice. In Tph -/gut microbiota, it revealed a reduction in Bacteroidales compared to Tph +/+ mice. At the same time the gut microbiota of Tph -/exhibited raised abundance of Akkermansia than Tph +/-. [22] Malignancy Gut microbiota is now being increasingly associated with the development of colorectal cancer. [23] One of the most important causes invariably contributing to the development of colorectal cancer is diet. [23] Diet has an impact on initiation, progression or prevention of colorectal rectal cancer (CRC). DNA damage, pro-inflammatory cytokines changes, proto-oncogenes activation resulting in gut microbiota modulation and inducing obesity. [24] CRC mucosa tissue investigated from patients exhibited an over the presentation of Coriobacteridae, especially genera Slackia and Collinsella, which are gut commensals. There was also an under presentation of Enterobacteriaceae such as Citrobacter, Shigella, Cronobacter, Kluyvera, Serratia and Salmonella spp. in CRC tissue. [25] Bifidobacterium longum and Bifidobacterium breve administered in animal model improved cancer control. Lactobacillus lactis administered in mouse model reduced catalase activity and hydrogen peroxide concentration, thereby reducing colonic damage and inflammation. [26] 
Vascular
Oral microbiota or gut flora may lead to the translocation atherosclerotic plaques, thereby leading to the development of atherosclerosis. Dietary components may alter the composition of gut flora or metabolites can be processed that may delay or enhance the development of atherosclerosis. Bacterial metabolites like trimethylamine N-oxide (TMAO) is harmful and influences thrombotic activity and cholesterol metabolism. [27] The role of gut microbiota in atherosclerosis demonstrated using a mouse model found that the gut microbiota metabolised dietary lipid phosphatidylcholine to trimethylamine and its conversion in liver to TMAO, induces atherosclerosis.
On sequencing the atherosclerotic plaques in patients with symptoms, the predominant bacteria were found to be from the genus Collinsella, when compared with controls whose gut was enriched with Roseburia and Eubacterium. Further characterisation of metagenome from the patient showed an increase in genes encoding for peptidoglycan, which helps in 'priming the innate immune system and enhancing neutrophil function', thereby leading to inflammation and a decrease in phytoene dehydrogenase and beta-carotene; having anti-oxidant activity. [28] Autoimmune
Celiac disease
Gut microbiota probably has a role to play in the occurrence of celiac disease. Although it has not been proven, it has been deduced that the gut bacteria may have a role play in the occurrence of autoimmune celiac disease. Celiac disease is a disorder of the digestive tract affecting mostly the small intestine; it brings about an autoimmune response. People having the disorder generally cannot ingest a protein called gluten found mostly in wheat, barley and rye. Pathogenesis is complex, mostly due to the genetic predisposition (HLA-DQ2 and HLA-DQ8 haplotypes) and exposure to prolamines which are specific group of proteins. [29] Studies have shown that patients with celiac disease had a decrease of Bifidobacterium, Lactobacillus, Faecalibacterium prausnitzii and an increase in Bacteroides/Prevotella and E. coli. [30] 
Rheumatoid arthritis
More recently, it has been found that gut bacteria play a role in the development of rheumatoid arthritis. Although the real cause for this chronic systemic autoimmune disease remains elusive, studies on gnotobiotic mice indicate a possible link between the gut microbiome and in the development of the disease. Studies have shown that with early rheumatoid arthritis, there is a notable change in the gut flora when compared with the healthy individuals and also an increase in Prevotella copri with reduction in Bacteroides in new-onset untreated rheumatoid arthritis [31] [ Table 2 ].
Alzheimer's disease
Numerous studies in mice models suggest there is a direct correlation between Alzheimer's disease and gut microbial alterations. In transgenus Alzheimer's disease mice, it was observed that there is a significant decrease in abundance of phyla Firmicutes and Actinobacteria and an increase in phyla Bacteroidetes and Tenericutes. Amyloid deposition in the cerebrum is the hallmark of Alzheimer's disease. Certain bacteria have shown to increase the amyloid production. In elderly individuals with cognitive impairment, a significant decrease in Eubacterium rectale and Bacteroides fragilis (anti-inflammatory genera) and increase in Escherichia and Shigella (pro-inflammatory genera) was observed in comparison to its elderly healthy counterparts. [1] 
Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Human intestine harbours a large quantity of bacteria which includes phyla Firmicutes, Bacteroidetes, Proteobacteria and one Arachaea. [32] Bacteroidetes is a predominant phylum which comprises of 20 genera, the most abundant of which is Bacteroides. Liver shows close connection with the gut anatomically and functionally through the portal circulation.
Endotoxaemia and gut-derived toxins participate in the onset and progression of liver inflammation and lead to fatty liver. Non-alcoholic fatty liver disease (NAFLD) encompasses the metabolic syndrome and pathological changes, including steatosis, non-alcoholic steatohepatitis (NASH), fibrosis and cirrhosis. Obesity and T2DM have an important role in this. Diet-induced bacterial overload may cause gut leakiness and elevated level of endotoxin absorption leading to NAFLD in human. [33] NASH is a typical multifactorial liver disease. Dysbiosis effect intestinal permeability and cause NASH. It activates toll-like receptor-4 and leads to inflammation of the liver. Gut microbiota alters digestion and absorption of nutrients and production of gut hormones. Western diets that are rich in fat, animal proteins and sugar may be associated with NASH. [34] Fructose intake has been largely increasing in the recent years. The liver is the site of fructose metabolism, because it contains Glut-5 fructose specific receptor. It promotes de novo lipogenesis and stimulates triglyceride synthesis. It is also more prone to induce obesity with fatty liver. Endotoxaemia promotes the development of steatosis, inflammation and hepatic fibrogenesis. [35] Lachnospiraceae bacterium 609 and Barnesiella intestinihominis was raised significantly in the mice stool which had potency to develop NAFLDl; however, in controls, Bacteroides vulgatus had drastically reduced. Lactobacillus gasseri and Lactobacillus taiwanensis were abundant in mice fed with low-fat and high-fat diet. [36] 
Metabolic disorders Type 2 diabetes mellitus
A study from the Chinese population clearly demonstrates that there is a moderate degree of change in the gut microbiota of T2DM patients when compared to the healthy control participants. However, there is a significant decrease in butyrate-producing bacteria (Clostridales, Faecalibacterium Roseburia) in T2DM when compared to healthy individuals. These butyrate-producing bacteria have anti-inflammatory properties.
A low-grade inflammation is noted in T2DM population and diabetic mice due to increased levels of plasma lipopolysaccharides (LPSs) (membrane component of Gram-negative bacteria). In animal models, this increase in LPS has shown to impair the glucose metabolism. An Indian study showed a significant increase in Escherichia and other Gram-negative bacteria in T2DM when compared to their healthy counterparts. This increase in Gram-negatives could potentially stimulate the metabolic endotoxaemia.
This low-grade inflammation is also clearly demonstrated by increase in the pro-inflammatory markers monocyte chemoattractant protein-1 and interferon-gamma in the T2DM population when compared to healthy controls.
Type 1 diabetes mellitus
Gut immune system gets altered in the development of type 1 DM, it affects the innate and adaptive immune system, and there is an immunological change between the gut and pancreas, which also affects the pancreas. Studies done in individuals having type 1 diabetes showed a decrease in Firmicutes and an increase in Bacteroidetes. [37] De Goffan et al. observed reduced abundance of lactate and butyrate-producing bacterial species, dominant being Bifidobacterium adolescentis and Bifidobacterium pseudocatenulatum also a raised abundance of genus Bacteroides, showing an altered gut microbiota in children having islet autoantibodies which is associated with β-cell autoimmunity [38] [ Table 2 ].
rOle Of gut flOra in the pathOgeneSiS Of OBeSity, diaBeteS MellituS itS cOntrOl and itS cOMplicatiOnS
The link between gut microbiota and metabolic disorders such as obesity is well established. [39] However, the treatment modalities for obesity currently rely on strategies that do not majorly alter the gut microbiota.
Low-grade chronic inflammation is usually observed in gut microbiota dysbiosis, leading to increased permeability of the intestine and increased systemic levels of bacterial products. The low-grade chronic inflammation may lead to insulin resistance and concomitant effect on the plasma lipids. It has been well established that there is a low-grade inflammation in obese model and increased expression of cytokines such as tumour necrosis factor-alpha. The LPS from the cell wall of the Gram-negative bacteria was found in low concentration in the blood of healthy individuals. Diet-induced obesity and other metabolic disorders show an increase in the LPS concentration.
We observed the co-existence of bacterial species as bacterial communities. The synergistic mechanism behind the co-existence of bacterial species is unclear. The cell wall of Gram-negative bacteria is rich in LPS, and the gut of human acts as a reservoir for LPS. These LPSs will increase the body weight and lead to obesity and will increase the energy extraction. This extra energy along with a sedentary lifestyle results in fat deposition. Bacterial community of 'good bacteria', when found together, will create wellness. The gut microbiota seems to change with the replacement of certain bacteria by the other. It is possible that (a) proportion of Gram-negative bacteria predominate and create dysbiosis and are harmful and (b) proportion of Gram-negative bacteria predominates along with certain species of Gram-positive bacteria and contribute to this harm by some mechanism, which allows for co-existence.
The immune system recognises bacteria and bacterial products by a pattern recognition receptor such as toll-like receptor (TLR). Bacterial ligands recognised by TLRs are produced by the commensal microorganisms, which prevent injury to the gut upon activation. All TLRs as well as IL-1 receptor and IL-18 receptor use a signalling adapter MyD88. In addition to the TLR, bacterial products are recognised by intracellular nucleotide-binding oligomerisation domain-like receptors (NOD-like receptors, NLR), which activate nuclear factor kappa B (NF-κB), which in turn leads to the release of pro-inflammatory cytokines. Interaction between bacteria in the gut and TLR controls local inflammation and mucosal homeostasis. Dysregulation of commensal microorganism and TLRs promotes chronic inflammation. It has been suggested that LPS and CD14 set the tone for insulin sensitivity and regulates onset of obesity and DM.
iMpact Of dietary interventiOnS On gut MicrOBiOta Diet
A study conducted on high-fat, carbohydrate-free diet mice has shown that antibiotic treatment was associated with changes in gut microbiota and endotoxaemia when on a high-fat diet. The faecal contents of the antibiotic-treated mice contained decreased endotoxin level. High-fat feeding, to increased intestinal permeability associated with a reduced expression of epithelial tight junction protein such as Zonula Occludens-1 and Occludin; were also reversed when antibiotics were administered, although it was only for occludin, showing that the gut bacteria play a role in controlling intestinal permeability. Lipid content was also increased in these mice, suggesting that intestinal microflora also play a role in energy harvest. Levels of inflammatory cytokines which are produced during inflammation, leading to oxidative stress and increases during a high-fat diet were also totally blunted. [40] The size of the adipocytes which increases during intake of high-fat diet decreased with use of antibiotics. Improved glucose tolerance levels in the mice after antibiotic treatment also showed that a strong relationship exists between the gut microbiota and metabolic endotoxaemia and inflammation during a high-fat diet. The mechanism of high-fat diet-induced inflammation and metabolic disorders were linked to changes in the gut microbiota, LPS and endotoxaemia. This high plasma level of LPS leading to endotoxin production is due to changes in the gut microbiota. Evidence has shown that in the absence of endotoxaemia, dietary lipids failed to produce metabolic disorders. [40] 
Probiotics or prebiotics
Studies have shown that probiotics and prebiotics help to prevent and restore the normal flora when given to patients in who gut microbiota has been altered for e.g., Clostridium difficle associated diarrhoea, inflammatory bowel syndrome and disease, liver disease and colon cancer. Although it has not yet been proven, preliminary reports suggest that the gut microbiota have beneficial effect. [41] Prebiotics are substances fermented by bacteria in the gut and have a beneficial effect in changing the composition of a specific microbiota, although it is unclear whether this intervention promotes stability and microbial shifts which is not reflective of patient's original colonisation pattern. Prebiotics are carbohydrate molecules which are either short or long chain which does not get absorbed in the small bowel and are fermented in the colon into SCFA and gas. Prebiotics influence the gut flora resulting in a raise of Bifidobacteria and a drop in the colonic pH. Intake of prebiotics inhibit fermentation by existing specific strain in the gut, thereby prevents digestion and absorption by the host. Fructooligosaccharide (FOS) and glucooligosaccharide are commonly used as probiotics [ Figure 1 ].
There are several different types of prebiotics, and they are extracted from various sources. FOSs is generally found in asparagus, sugar beet, garlic, chicory, onion, Jerusalem artichoke, wheat, honey, banana, barley, tomato and rye. [42] Isomaltulose is another type found commonly in honey and sugarcane juice. Xylooligosaccharides is extracted from bamboo shoots, fruits, vegetables, milk, honey and wheat bran. Galactooligosaccharides are commonly found in human's milk and cow's milk. Cyclodextrins are seen in water-soluble glucans. Raffinose oligosaccharides are found in the seeds of legumes, lentils, peas, beans, chickpeas, mallow composite and mustard. Soybean oligosaccharide is commonly found in soybean. Lactulose is commonly seen in lactose (milk). Lactosucrose is also seen in lactose. Isomaltulose and palatinose are obtained from sucrose. Maltooligosaccharides and isomaltooligosaccharides are derived from starch. Arabinoxylooligosaccharides is extracted from wheat bran. [43] Enzyme-resistant dextrin is derived from potato starch. Recent studies explored the prebiotic potential in red kidney bean. Red kidney bean (Phaseolus vulgaris) has a prebiotic and biofilm inhibiting potential. [44] Red kidney bean water-extractable polysaccharide (RKBWEP) stimulates the growth of Lactobacillus plantarum and L. fermentum which are probiotic bacteria. RKBWEP stimulates the growth of good bacteria such as Bifidobacterium spp. and Lactobacillus spp. in vitro in faecal fermentation batch in about a day's time. It was also observed that during RKBWEP fermentation, SCFAs such as acetic acid, propionic acid and butyric acid concentration spiked and attained maximum level after 48 h time. [44] Probiotics are live organisms when administered provide a beneficial effect. Prebiotics, on the other hand, are non-digestible food components that selectively stimulate the growth or activity of bacteria thereby improving the hosts' health. Both are used in the treatment of many gut-associated changes more commonly in acute diarrheal, traveller's diarrhoea, antibiotic-associated diarrhoea, radiation-induced diarrhoea and also in non-gastrointestinal causes such as non-alcoholic fatty liver, necrotising enterocolitis, allergy and hepatic encephalopathy. [45] Although bacteria are the ones commonly used, some fungi are also used. [45] Probiotics act by stimulating intestinal mucosal immune and non-immune mechanisms, whereas prebiotics act by increasing the number of anaerobic bacteria and decreasing pathological microorganisms. The main disadvantage in using these as treatment options is that the products are not tested for purity, viability or effectiveness.
Most common microorganisms that are used as probiotic are Gram-positive bacteria, although some Gram-negative bacteria are also used. These probiotics are used to treat many intestinal maladies such as IBD, constipation and CRC. [46] For intestinal dysfunction, the main species used is Lactobacillus and Bifidobacterium. Gram-negative bacteria are also used, such as E. coli Nissle 1917 (EcN), used for the treatment of chronic constipation, and colitis in Germany. Yogurt, cheese and pickles are rich in Gram-positive microbes, which are being used intensely by the food processing industry. The most commonly used probiotic strain is lactic acid bacteria (LAB). The LAB species like Lactococcus lactis is used for cytokine delivery and is transiently present in the human gut. The property of transient colonisation of the gut is beneficial and can be used as a vehicle for protein vaccines like DNA vaccines. The Gram-negative probiotics, EcN strain is contained in a drug called mutaflor which is used for treating IBD and infectious diarrheal disease. EcN is given to neonates to prevent multidrug-resistant pathogens from colonising the gut. [47] 
Figure 1: Impact of dietary interventions on gut microbiota
Probiotic food products are either diary-based or non-diary based. Common diary-based products are acidophilus milk drink, acidophilus butter, banana-based yogurt, cottage cheese, fermented goat's milk, frozen yogurt, kazar cheese, probiotic ice cream, whey protein-based drinks and corn milk yogurt. The non-dairy products include cereal and legume based, fruit juices and vegetable juices. The cereal and legume based and wheat-fermented probiotic beverages, soy-based drink and frozen desserts, oat-based products and drinks. Fruit juices are pineapple, grape, watermelon, blackcurrant juice, cashew and apple juice. Vegetable juices such as beet-based drink, tomato-based drink and ginger juice.
Antibiotics
Antibiotics lead to disruption and deletion of gut bacteria, but they do have potential beneficial effects when used properly.
In patients with C. difficle-associated diarrhoea, irritable bowel syndrome and inflammatory bowel diseases, antibiotics play an effective role in treatment, although one has to remember the side effects in the long run including acquiring resistance by the bacteria towards the antibiotic.
Faecal microbial transplantation
In a recent study conducted in England on patients with recurrent C. difficle infection, it was found that, patients treated with faecal microbial transplantation had a 94% cure rate than those treated on antibiotic alone or antibiotic associated with bowel lavage (27) . There was an increase in Bacteroidetes and Firmicutes (Clostridium clusters IV and XIVa) level after infusion and there was no relapse. [48] The transfusion of faecal microbiota had such an impact on the subjects assigned to receive the microbial transfusion, that the study was terminated and transfusion of donor microbiota was given to the other patients. [48] Studies have shown that when microbiota from obese individuals were transferred to germ-free mice, the obese phenotype was transferred to the mice, suggesting a link between altered gut microbiota and development of obesity and also indicating that this concept can be used in transferring gut microbiota from an healthy individual to another for healthy living.
Similarly, studies on infusing intestinal microbiota from lean donors to individuals with metabolic syndrome improved insulin sensitivity in 6 weeks with additional improvement in the butyrate-producing gut bacteria. Thus, intestinal microbial transplantation will help in the prevention of not only diabetes mellitus and obesity, but also other gut involved problems. However, it is not clear as to what extent the effect can last, whether one-time transfusion is enough or if it has to be done on a regular basis. It is also not clear if treatment with faecal transplantation alone is enough or does it need to be supplemented with probiotics.
Although transplantation of faecal microbiota has a very good outcome as seen in the previous studies, it would be quite challenging to administer faeces without transmitting any disease. In the above study, the donor stools were screened for parasites and enteropathogenic bacteria. [48] In addition, testing of blood samples was done for HIV, Hepatitis A, B and C, T-cell lymphotropic viruses, Treponema pallidum, Entamoeba histolytica, EB virus and CMV; also a donor pool had been created which was screened once every 4 months. [48] Further, it may be unappealing for the patient receiving faecal transplantation; many may not opt for this type of treatment unless dire need arises or the patient is critical. Another difficulty would be the mode of administration of the transplants; since not many clinical trials have been done in this area, it is also not clear which mode of transplantation of the donor faeces is more feasible than the others and also how much of faeces need to be transfused for the optimum result to be obtained, [48] immune reactions may occur. The phylogenetic abundance of the recipient's gut microbiota is restored without delaying the perturbation of the normal flora, in faecal microbial transplant therapy [49] [ Figure 2 ].
Immune modulators and phage therapy
Immune system plays an important role in disease status. It is known that in conditions such as IBD, immune system plays an important role, and it has been shown that mice lacking immune modulators such as IL-10 and others have a different type of gut microbiota. This being the beginning of research in this area not much detail is available regarding its usefulness in reshaping the microbiota. Phage therapy is another method where specific bacteriophages can be used to target a particular microbe; although it does come with an adverse effect of phage resistance in the long run, this is an unproven area and not much research or data is available. [50] unanSwered queStiOnS and areaS fOr future reSearch
There are no studies yet to prove as to how this microbiota is transmitted; although some studies in mice show a vertical transmission is possible, [8] it remains to be proved as to how an individual acquires his/her own specific microbiota. It is also not known whether the gut microbiota have exchanged genes with microbes from other habitat; since this is the fundamental process of microbial evolution 'the gut is a natural laboratory for studying genome evolution within spatially distinct habitat islands', [51] if this has happened, then there is a possibility that the genes of bacteria in the gut and the others from environment are being similar which in the future can help in further study.
Another question yet to be answered is, when the gut is altered by means of diet, which has an impact on health, whether this would help prevent the occurrence of disease from the start or after the disease has developed. It is also not known if it is possible to reverse the condition by means of diet or reduce the morbidity level that the disease usually causes. From the perspective of treatment, the use of probiotics/prebiotics still remains a challenge and a scope for future research in the treatment of obesity and diabetes mellitus; although its role has been proven in IBD and colon cancer and each of us having a specific set of gut colonisers, it would prove a challenging and difficult task providing a probiotics or prebiotic that complies with everyone's gut. The gut flora at the Arachaea level follows not so similar rules than the bacteria. [51] They are yet to be studied to know if they would be useful from a therapeutic point. In addition to the above options for treatment, immune modulators and phages can be used in treatment. This is a novel concept and not much study has been done using them, they may prove a good option for future research in therapy for modulating the gut for beneficial effects, but not without possible disadvantages of their own. [50] Financial support and sponsorship Nil.
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